COPD Management

Bilim Pharmaceuticals, H&T Presspart and Hovione Collaborate | 9/1/2020

… a pharmaceutical specialist in the development of innovative pulmonary device technology, are collaborating to support Bilim Pharmaceutical’s launch into the Turkish market of Ventofor Combi Fix, a formulation of Budesonide Formoterol for Asthma and COPD management, delivered by the PowdAir Plus Dry Powder Inhaler (DPI). Treating Asthma in Turkey Worldwide over 500 million people suffer from Asthma and COPD. In Turkey, there is growing patient demand for effective, readily accessible …

Zhongchao Inc. Develops Live Interactive Courses Promoting the Global Initiative for Chronic Obstructive Lung Disease | PR Newswire | 8/11/2020

… a global initiative to raise awareness of chronic obstructive pulmonary disease (“COPD”) and to improve prevention and treatment of this lung disease for patients around the world. GOLD’s primary objectives include: i) Recommend effective COPD management and prevention strategies for use in all countries; ii) Increase awareness of the medical community, public health officials and the general public that COPD is a public health problem; iii) Decrease morbidity and mortality …

Follow COPD Management:    

Breztri Aerosphere Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial | 6/25/2020

… support the strong clinical profile of Breztri Aerosphere in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of Breztri Aerosphere were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection …

PT010 Significantly Reduced Rate of Moderate or Severe COPD Exacerbations in Phase III ETHOS Trial | Financial Buzz | 6/25/2020

… trial support the strong clinical profile of PT010 in reducing exacerbation rates compared with dual-combination therapies. We are excited to have the data on all-cause mortality, which is a key consideration for COPD management.” The safety and tolerability of PT010 were consistent with the known profiles of the dual comparators. In the trial, the most frequently reported adverse events were nasopharyngitis, COPD and upper respiratory tract infection. The …

Advanced Non-contact Patient Monitoring Technologies: A New Paradigm in Healthcare Monitoring - ResearchAndMarkets.com | Business Wire | 6/5/2020

… Growth Opportunities: Sound Analysis Technologies will Experience High Adoption for Remote Monitoring of Older Patients in Home Settings 3.2.5 Application Growth Opportunities: Non-contact Chronic Cough Sound Monitoring Can Play a Significant Role in COPD Management 3.3 Video Analysis Technology 3.3.1 AI-powered, Video-based Vital Signs Monitoring 3.3.2 3D Motion Tracking Technology for Estimating Heart Rate and Rhythm 3.3.3 Breathing Pattern Analysis Based on Acquired Video Data 3.3.4 Video …

Remote Patient Monitoring and COVID-19 - Mobile-based Platforms, AI-based Algorithms, and Video Analysis Defining New Approaches | PR Newswire | 6/5/2020

… Growth Opportunities: Sound Analysis Technologies will Experience High Adoption for Remote Monitoring of Older Patients in Home Settings 3.2.5 Application Growth Opportunities: Non-contact Chronic Cough Sound Monitoring Can Play a Significant Role in COPD Management 3.3 Video Analysis Technology 3.3.1 AI-powered, Video-based Vital Signs Monitoring 3.3.2 3D Motion Tracking Technology for Estimating Heart Rate and Rhythm 3.3.3 Breathing Pattern Analysis Based on Acquired Video Data 3.3.4 Video …

Measuring disease activity in COPD: is clinically important deterioration the answer? | 6/2/2020

… medium-term outcomes compared with any single CID component alone, and that it can demonstrate differences in treatment efficacy in short-term trials. Given the widely acknowledged need for an individualized holistic approach to COPD management, monitoring short-term CID has the potential to facilitate early identification of suboptimal treatment responses and patients at risk of increased disease progression. CID monitoring may lead to better-informed clinical management decisions and …

COPD: Importance of Educating Patients on Proper Inhalation Technique | 3/16/2020

Practitioners can play a vital role in providing education and training on correct inhalation techniques to enhance therapeutic benefit and optimal medication delivery. Treatment of COPD Maintenance pharmacotherapy with long-acting bronchodilators is the cornerstone of COPD management . Bronchodilators can be short-acting or long-acting . Long-acting bronchodilators include long-acting beta 2 agonists (LABAs) and long-acting muscarinic antagonists (LAMAs). When used together, the 2 medications have improved …

COPD Awareness Month – Take Control of Your Respiratory Heath | 11/26/2019

… Awareness Month? COPD Awareness Month is celebrated around the world throughout November and is designed as a way for individuals to learn more about this disease while providing increased support for those currently seeking COPD management. With over 15.3 million Americans currently diagnosed with COPD, most people know someone with this disease. However, it is highly likely that millions more adults have this disease but have not yet been diagnosed …

Diagnosed with COPD? you Can take charge Of Your Health! | 11/26/2019

… burden COPD can cause in your daily life. As a Clinical Pharmacist who focuses on improving patient outcomes, it is my passion to empower my patients with the knowledge and tools they need for COPD management and to overcome the fear and anxiety of being labeled with a Chronic Respiratory condition. Moment of Truth You just found out why you run out of breath so quickly, wheeze once in a …

World COPD Day: Pulmonologist Tells Everything You Ever Wanted To Know About COPD | 11/20/2019

Drink plenty of fluids for COPD management Maintaining a healthy weight is also important Be on point with your medicines to control COPD World COPD Day: November 20 is observed as World Chronic Obstructive Pulmonary Disease (COPD) Day. This day is meant to raise awareness about COPD which is referred to a group of slowly progressing lung diseases. Emphysema and chronic bronchitis are common lung diseases. Emphysema slowly destroys air …

Self-management interventions in COPD patients with multimorbidity | 11/7/2019

… adapt their behaviours and develop skills to better manage their disease. Exacerbation action plans are a key component of COPD self-management interventions [ 1 , 2 ], and self-management interventions are a key component of COPD management [ 3 ]. However, studies assessing these interventions show contradictory results, particularly depending on the primary outcome, e.g. quality of life, exacerbations, re-hospitalisations or mortality [ 1 , 2 , 4 ]. Self-management interventions, including a COPD exacerbation …

11.9 Bn Electronic Drug Delivery Systems Market - Global Forecast to 2024 | PR Newswire | 10/22/2019

… 6.1.3 Electronic Injection Pens 6.1.3.1 Growing Focus of Pharmaceutical Companies on Developing Electronic/Connected Injection Pens Will Drive Market Growth 6.1.4 Electronic Inhalers 6.1.4.1 Electronic Inhalers are Developed to Improve Medication Adherence in Asthma & COPD Management 7 Market, By Indication 7.1 Introduction 7.2 Diabetes 7.2.1 Diabetes Accounted for the Largest Segment of the Market 7.3 Multiple Sclerosis 7.3.1 Launch of Generic Versions of Conventional Injectables Will Stifle Market Growth 7.4 …

Sanjay Sethi, MD: Aclidinium Bromide in COPD | MD Magazine | 10/21/2019

… chronic and a risk of cardiovascular events. The findings evidence what clinicians including Sanjay Sethi, MD, have already known: that bronchodilation is integral to exacerbation reduction—and exacerbation reduction is the key to proper COPD management. In an interview with MD Magazine® while at CHEST, Sethi, professor of Medicine at the University of Buffalo, explained the long-term benefit of COPD bronchodilation, and newly understood safety of aclidinium bromide in …

Assessing spirituality: is there a beneficial role in the management of COPD? | Nature | 5/28/2019

… conceptualized as an integral part of the social-natural environment. 31 This concept is embedded in a general cultural approach of keeping a balanced life status and being mindful. 31 This has advantages in COPD management, with promising results from mindfulness-based interventions added in pulmonary rehabilitation (PR). 32 Importantly, literature reveals the desire of patients for their religion/spiritual needs to be included in their medical care, especially at …

Chronic Obstructive Pulmonary Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 -2026 | Markets Insider | Business Insider | 4/11/2019

… awareness about COPD treatment are the key factors anticipated to drive the global market. Read the full report: https://www.reportlinker.com/p05750465/?utm_source=PRN Additionally, increase in the geriatric population, rise in importance of COPD management, and surge in the number of respiratory care centers contribute to the growth of the global market. According to the Global Initiative for Asthma (GINA) 2018, COPD is the third leading cause of death …

Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation In Europe For The Treatment Of COPD - TheStreet | 11/16/2017

… to achieve treatment goals. Trelegy Ellipta is the first medicine to be approved in Europe that delivers three effective molecules in a once-daily single inhalation. We believe this is an important innovation in COPD management and look forward to making it available for appropriate patients with COPD.” Mike Aguiar, CEO of Innoviva, Inc., said, “Knowing that appropriate COPD patients will require triple therapy, Trelegy Ellipta affords the convenience of …

Koninklijke Philips NV’s (PHG) CEO Frans van Houten on Q3 2017 Results - Earnings Call Transcript | Seeking Alpha | 10/23/2017

… patients, home care workers, doctors, hospitals and payers all enabled by our health suite digital could platform. The combination of the connector Trilogy ventilator and the care service provides a clinically validated solution for COPD management which is expected to help providers lower care cost and reduce hospital admissions while improving the patient experience. We launched a global brand campaign to help us leverage the Philips brand as a key …

Respiratory Care

COPD Awareness Month – Take Control of Your Respiratory Heath | 11/26/2019

… designed as a way for individuals to learn more about this disease while providing increased support for those currently seeking COPD management. With over 15.3 million Americans currently diagnosed with COPD, most people know someone … Without treatment, early death is likely, but lifestyle changes, appropriate respiratory care and emotional support can help individuals find better quality of life. What Are Causes of and Risk Factors for COPD? A huge majority …

Benefits of the ‘village: a qualitative exploration of the patient experience of COPD in rural Australia | BMJ | 10/8/2019

… provided of close, trusting, long-term relationships with doctors, health professionals ‘going above and beyond’ and social supports that enabled COPD management within the rural context. Similarly, self-management of COPD has been depicted as … focuses on deficits in care and experience, 46 and that respiratory care within the explored region is based on a rural generalist model, participants in this study did not speak of ‘missing out’ on services …

GSK

Inhaler devices and global warming: Flawed arguments | BMJ | 11/8/2019

… also be made. This was performed by Jeswani and Azapagic (31)for pMDIs made with HFA134, HFA227, HFA152 and a GSK dry powder inhaler Diskus device. Although the DPI outperformed the HFA134 and HFA227 inhaled … inappropriately stopping or switching inhalers. In our view, asthma and COPD management should focus on prescribing appropriate inhaler devices and ancillary equipment such as spacers that individual patients are able to use efficiently after appropriate …

Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation In Europe For The Treatment Of COPD - TheStreet | 11/16/2017

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has granted marketing authorisation for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, ‘FF/UMEC/VI’) as a maintenance treatment in … single inhalation. We believe this is an important innovation in COPD management and look forward to making it available for appropriate patients with COPD.” Mike Aguiar, CEO of Innoviva, Inc., said, “Knowing that appropriate COPD …

GlaxoSmithKline

Inhaler devices and global warming: Flawed arguments | BMJ | 11/8/2019

… effects on the environment related to the stages of manufacture of pMDIs and DPIs. For example, in the case of GlaxoSmithKline products, the majority of the CO2 emissions from this company’s DPI devices arise from … inappropriately stopping or switching inhalers. In our view, asthma and COPD management should focus on prescribing appropriate inhaler devices and ancillary equipment such as spacers that individual patients are able to use efficiently after appropriate …

Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation In Europe For The Treatment Of COPD - TheStreet | 11/16/2017

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has granted marketing authorisation for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol, ‘FF/UMEC/VI’) as a maintenance treatment in … single inhalation. We believe this is an important innovation in COPD management and look forward to making it available for appropriate patients with COPD.” Mike Aguiar, CEO of Innoviva, Inc., said, “Knowing that appropriate COPD …